Celebrating Dr. Michael Para

CCTS Recruitment Program Director celebrates 30 year anniversary of study

Thirty years ago, Michael Para, MD, professor of Infectious Diseases and Program Director of CCTS Recruitment, enrolled the first participant into an HIV/AIDS research study – the AIDS Clinical Trials Group 019.  In 1990, the results of this placebo-controlled study conducted within the AIDS Clinical Trials Group showed that in the short term, zidovudine was effective in slowing progression to advanced disease in HIV-infected asymptomatic patients with low CD4 cell counts. 

We’ve come a long way since that first study. Thank you, Dr. Para, for thirty years of service to this community!

Learn more about Dr. Para